Phase II Study of the Combination of Bendamustine and Dexamethasone in Patients With Relapsed AL Amyloidosis
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 23 Jun 2017
At a glance
- Drugs Bendamustine (Primary) ; Dexamethasone (Primary)
- Indications Amyloid light-chain amyloidosis
- Focus Therapeutic Use
- 14 Jan 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2021.
- 14 Jan 2017 Planned primary completion date changed from 1 Nov 2016 to 1 Dec 2017.
- 06 Dec 2016 Results of final analysis (n=31) presented at the 58th Annual Meeting and Exposition of the American Society of Hematology